Control Group:ACEI/ARB
Sponsors
Department of Nephrology, Shenzhen Second People's Hospital, Zhongshan Hospital Fudan University, The First Affiliated Hospital of Harbin Medical University, Institute of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Southern Hospital of Southern Medical University
Conditions
Diabetic kidney diseaseacute heart failurediabetic nephropathyfocal segmental glomerulosclerosisheart failure
Early Phase 1
Phase 4
Clinical research of liu wei di huang pill combined with ACEI/ARB on patients with early-stage diabetic nephropathy
Active, not recruitingChiCTR-TRC-12002401
Start: 2010-12-01Updated: 2017-04-18
Clinical research of Guifu Dihuang pill combined with ACEI/ARB on patients with early-stage diabetic nephropathy
Active, not recruitingChiCTR-TRC-12002822
Start: 2010-12-01Updated: 2017-04-18
Glucocorticoids in the treatment of patients with primary focal segmental glomerulosclerosis and moderate proteinuria
Active, not recruitingChiCTR-OPN-17012789
Start: 2006-06-01Updated: 2017-10-02
A real world study of the effectiveness and safety of canagliflozin in the treatment of diabetic nephropathy
RecruitingChiCTR2000032137
Start: 2020-06-01Updated: 2020-07-20
Clinical study on the efficacy and safety of Sacubitril/ Valsartan in patients with acute decompensation of chronic heart failure
Active, not recruitingChiCTR2100046851
Start: 2017-10-30Updated: 2022-01-10